Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$34,252
in 1 filing

Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis Mark Steven −$34K Director sold 6% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-09-30 Ford Alexander President, MGL Returned to the company −6,653 $46.00 $306K 120,524
2018-09-30 Tobin Bernard President Crescendo BioScience Returned to the company −4,958 $46.00 $228K 167,635
2018-09-30 Tobin Bernard President Crescendo BioScience Returned to the company −6,149 $46.00 $283K 161,486
2018-09-30 Riggsbee Richard Bryan Chief Financial Officer Returned to the company −5,289 $46.00 $243K 156,946
2018-09-30 Riggsbee Richard Bryan Chief Financial Officer Returned to the company −6,653 $46.00 $306K 150,293
2018-09-30 McDade Ralph L President Myriad RBM, Inc. Returned to the company −2,361 $46.00 $109K 127,217
2018-09-30 McDade Ralph L President Myriad RBM, Inc. Returned to the company −2,952 $46.00 $136K 124,265
2018-09-30 Verratti Mark President Assurex Health Inc. Returned to the company −725 $46.00 $33K 85,578
2018-09-30 King Gary A. Exec. VP International Ops Returned to the company −3,826 $46.00 $176K 137,300
2018-09-30 King Gary A. Exec. VP International Ops Returned to the company −3,327 $46.00 $153K 133,973
2018-09-30 Capone Mark Christopher President & C.E.O. Returned to the company −18,295 $46.00 $842K 449,560
2018-09-30 Capone Mark Christopher President & C.E.O. Returned to the company −8,727 $46.00 $401K 440,833
2018-09-30 Sanders Walter Lloyd President Myriad Oncology Returned to the company −629 $46.00 $29K 36,824
2018-09-30 Sanders Walter Lloyd President Myriad Oncology Returned to the company −629 $46.00 $29K 36,195
2018-09-30 LANCHBURY JERRY S Chief Scientific Officer Returned to the company −5,544 $46.00 $255K 171,206
2018-09-30 LANCHBURY JERRY S Chief Scientific Officer Returned to the company −5,157 $46.00 $237K 166,049
2018-09-30 MARSH RICHARD M E.V.P., General Counsel Returned to the company −4,998 $46.00 $230K 149,718
2018-09-30 MARSH RICHARD M E.V.P., General Counsel Returned to the company −5,544 $46.00 $255K 144,174
2018-09-25 Ford Alexander President, MGL Returned to the company −6,653 $46.65 $310K 129,007
2018-09-25 Tobin Bernard President Crescendo BioScience Returned to the company −4,958 $46.65 $231K 172,593

Page 38 of 60 · 1,194 trades